For the quarter ending 2025-09-30, FULC has $214,858K in assets. $16,492K in debts. $47,078K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 47,078 | 42,588 | ||
| Marketable securities | 153,567 | 171,523 | ||
| Unbilled accounts receivable | 0 | 0 | ||
| Prepaid expenses and other current assets | 5,218 | 5,262 | ||
| Total current assets | 205,863 | 219,373 | ||
| Total property and equipment | 18,471 | - | ||
| Less accumulated depreciation | 15,300 | - | ||
| Property and equipment, net | 3,171 | 3,269 | ||
| Operating lease right-of-use assets | 4,614 | 4,979 | ||
| Restricted cash | 1,201 | 1,205 | ||
| Other assets | 9 | 12 | ||
| Total assets | 214,858 | 228,838 | ||
| Accounts payable | 2,856 | 1,751 | ||
| Accrued expenses and other current liabilities | 6,428 | 4,941 | ||
| Operating lease liability, current | 2,348 | 2,293 | ||
| Total current liabilities | 11,632 | 8,985 | ||
| Operating lease liability, excluding current portion | 4,663 | 5,278 | ||
| Other liabilities, excluding current portion | 197 | 197 | ||
| Total liabilities | 16,492 | 14,460 | ||
| Common stock, 0.001 par value 200,000,000 shares authorized 54,108,438 and 53,968,303 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 54 | 54 | ||
| Additional paid-in capital | 772,015 | 768,591 | ||
| Accumulated other comprehensive gain | 241 | 82 | ||
| Accumulated deficit | -573,944 | -554,349 | ||
| Total stockholders equity | 198,366 | 214,378 | ||
| Total liabilities and stockholders equity | 214,858 | 228,838 | ||
Fulcrum Therapeutics, Inc. (FULC)
Fulcrum Therapeutics, Inc. (FULC)